Prospective Cutaneous Lymphoma International Prognostic Index Study by CheckRare Staff| Published on: Jun 8, 2026

Prospective Cutaneous Lymphoma International Prognostic Index Study by CheckRare Staff| Published on: Jun 8, 2026 Julia Scarisbrick, MD, MBhons, ChB, FRCP, is one of the leaders of the PROCLIPI (Prospective Cutaneous Lymphoma International Prognostic Index) study, a registry of patients with cutaneous T-cell lymphoma (CTCL). Dr. Scarisbrick, Professor of Dermatology, Department of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom, discussed the study’s objectives, as well as challenges in the diagnosis of CTCL. https://checkrare.com/prospective-cutaneous-lymphoma-international-prognostic-index-study/